EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the acceptability of COVID‐19 vaccine and its booster dose

Sawsan Mubarak, Ashraf A'aqoulah iD, Hadeel AlGhawrie, Samir Albalas iD, Nisreen Innab

Immunity, Inflammation and Disease · 2023

DOI: 10.1002/iid3.950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Sawsan Mubarak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Coronavirus disease of 2019 (COVID‐19) vaccinations are essential to control the pandemic and prevent severe COVID‐19 infections. This study aims to assess the acceptability of the COVID‐19 vaccine and the factors that impact the intention to take the COVID‐19 vaccine and its booster dose.

Methods

A cross‐sectional study was conducted in Saudi Arabia and Jordan. The study used a self‐administered web‐based survey (questionnaire) for data collection that was distributed via social media platforms from May 2022 to July 2022.

Results

In this study, among 518 participants, 54.4% had already received two doses of the COVID‐19 vaccine, and out of the participants who didn't receive the booster dose, 19.9% declared a definite willingness to receive it, while 42% had already taken a booster dose, which indicated good acceptance. After adjustment for significant background characteristics, a significant association between the country and receiving the COVID‐19 vaccine, the intention to get the vaccine, and infection with COVID‐19 were found, in addition to a significant association between the country and the participants' opinion that electronic applications helped them to follow their vaccine schedule were found ( p < .001). Also, the results showed that participants' attitudes were significantly associated with educational level and age groups ( p ≤ .001, p = .032, respectively). There was a significant association between the intention to receive the vaccine booster dose and the country ( p < .001). The Saudi participants were willing to get the booster dose seven times more than the Jordanians, furthermore, there was a significant association between taking the vaccine booster dose in the country, as well as age group, working in the medical field, previous COVID‐19 infection, and the intention to vaccinate the children ( p < .001, p = .030, .031, .025, < .001, respectively).

Conclusion

Overall, our results emphasize a positive response and a positive attitude toward COVID‐19 vaccination. In addition, define the groups to be targeted with effective communication regarding the COVID‐19 vaccine and its booster dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19ChildHumansCross-Sectional StudiesJordanPandemics

Stichwörter der Autor:innen

COVID-19booster dosecoronavirushealthcareimmunitypandemicvaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Infection Control Program, King Hussein Cancer Center, Amman, Jordan.
  • Department of Health Systems Management, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Department of Health Services Administration, Faculty of Economics and Administrative Sciences, Yarmouk University, Irbid, Jordan.
  • Department of Computer Science and Information Systems, College of Applied Sciences, AlMaarefa University, Saudi Arabia.

ORCID-Profile: Ashraf A'aqoulah, Samir Albalas

Zitieren

APA

Mubarak, S., A'aqoulah, A., AlGhawrie, H., Albalas, S., & Innab, N. (2023). Assessing the acceptability of COVID‐19 vaccine and its booster dose. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.950

Vancouver

Mubarak S, A'aqoulah A, AlGhawrie H, Albalas S, Innab N. Assessing the acceptability of COVID‐19 vaccine and its booster dose. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.950

BibTeX
@article{Mubarak2023,
  author = {Mubarak, Sawsan and A'aqoulah, Ashraf and AlGhawrie, Hadeel and Albalas, Samir and Innab, Nisreen},
  title = {Assessing the acceptability of COVID‐19 vaccine and its booster dose},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  doi = {10.1002/iid3.950}
}
Kostenlos starten →